• Menotropins
  • Humegnan®
  • Solution and Powder for Injection
  • 75 IU
  • Ampoule
  • -
Each Ampoule Contains:
Luteinizing Hormone (LH) 75 IU
Follicle-Stimulating Hormone (FSH) 75 IU 
Solvent:
1mL  NaCl 0.9% Solution
Ovulation Induction
Spermatogenesis 
Mechanism of Action
LH & FSH are pituitary gonadotropins that stimulate gonadal function, including spermatogenesis & ovulation 
Pharmacokinetics
Excretion: Urine
Contraindications
Pregnancy; may cause fetal harm
Hypersensitivity
High levels of FSH indicating primary ovarian failure
Presence of uncontrolled nongonadal endocrinopathies (eg, thyroid, adrenal, or pituitary disorders)
Sex hormone dependent tumors of the reproductive tract and accessory organ
Tumors of pituitary gland or hypothalamus
Abnormal uterine bleeding of undetermined origin
Ovarian cysts or enlargement of undetermined origin, not due to polycystic ovary syndrome
Adverse Reactions
 Headache , Abdominal pain, Nausea, OHSS, Injection site pain, Flushing, Dizziness, Malaise, Migraine, Breast tenderness, Hot flashes, Menstrual irregularities, Abdominal cramping/fullness, Constipation, Diarrhea, Ovarian disease, Vaginal hemorrhage, Back pain, Cough increased, Respiratory disorder, Flu-like syndrome
Major Drug Interactions
-
Warnings
Should be administered only by physicians thoroughly experienced in fertility disorders
Recommendations for Patient
-
Pregnancy Considerations
Category: X
Breastfeeding Considerations
Not known whether drug is excreted in breast milk, use caution



Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: Maybe acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.


Send to other people

http://en.dppharma.com/products/detail/humegnan75